Efficacy Preclinical Studies Conducted by UTRF, UTHSC, and Veru Inc.’s University-Industry Partnership Memphis, Tennessee: A research collaboration between the University of Tennessee Health Science Center (UTHSC), the University of Tennessee Research Foundation (UTRF), and biopharmaceutical company Veru Inc. has resulted in a promising next generation oral cancer therapy, VERU-111, which has the potential to treat (read more)
Inventions & Patents
UTRF Inventor Spotlight: Dr. Stephen Kania
On the frontlines to protect our furry friends. The endless battle to stay one step ahead of drug-resistant bacteria isn’t limited to humans; our four-legged friends are in the fight as well. Staphylococcus pseudintermedius, the bacteria behind staph infections, is the most common opportunistic pathogen in dogs. Dogs with underlying health problems, such as persistent (read more)
UT Researcher’s Nonwoven Fabrics Protect the Health of More Than a Billion People
Peter Tsai may not be a household name, but odds are you know his work. The recently retired research faculty member of Material Sciences is the architect behind the essential technology in N95 respirators. These respirators are required by OSHA when working in dusty environments to remove at least 95% of submicron particles, and recommended (read more)